Systematic identification of suspected anthelmintic benzimidazole metabolites using LC–MS/MS

[1]  G. Riggins,et al.  Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model , 2016, Oncotarget.

[2]  C. Rudin,et al.  Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. , 2015, Neuro-oncology.

[3]  E. Lacey,et al.  Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro. , 1985, Biochemical pharmacology.

[4]  H. Horn,et al.  Systematic suspect screening and identification of sulfonamide antibiotic transformation products in the aquatic environment , 2015, Analytical and Bioanalytical Chemistry.

[5]  G. Riggins,et al.  Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model , 2015, Clinical Cancer Research.

[6]  L. C. Davidse,et al.  Benzimidazole Fungicides: Mechanism of Action and Biological Impact , 1986 .

[7]  A. Spasov,et al.  Benzimidazole derivatives: Spectrum of pharmacological activity and toxicological properties (a review) , 2006, Pharmaceutical Chemistry Journal.

[8]  T. Watson,et al.  Identification of biliary metabolites of Mebendazole in the rat , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[9]  D. Gottschall,et al.  The metabolism of benzimidazole anthelmintics. , 1990, Parasitology today.

[10]  M. Roberts,et al.  The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man. , 1985, British journal of clinical pharmacology.

[11]  Q. Mckellar,et al.  Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys. , 2006, Veterinary journal.

[12]  M. Rouini,et al.  Effect of gender in the disposition of albendazole metabolites in humans , 2002, European Journal of Clinical Pharmacology.

[13]  D. Eastmond,et al.  Non-disjunction events induced by albendazole in human cells. , 2007, Mutation research.

[14]  C. Lanusse,et al.  Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. , 1993, Drug metabolism reviews.

[15]  E. Lacey.  Mode of action of benzimidazoles. , 1990, Parasitology today.

[16]  T. Tsuchiya,et al.  Metabolism of thiabendazole and teratogenic potential of its metabolites in pregnant mice. , 1987, Chemical & pharmaceutical bulletin.